In a selected group ofrhinitis palients with an IgE-mediated allergy to house dust mites the nasal response to insufflation of histamine chloride, methacholine and phentolamine was demonstrated to he higher than in a control group. With the methods used histamine chloride was better at discriminating between healthy subjects and patients than methacholine or phentolamine. This discrimination was shown by assessing the severity of reflex-mediated symptoms such as the number of sneezes and the amount of secretion, and not by differences in nasal airway resistance.
Introduction
Non-specific hyperreactivity is a well-known phenomenon in bronchial asthma, Hyperreactivity is characterized by quantitative changes in the response of lung function to bronchial provocation with substances such as histamine or methacholine [1] [2] [3] . Although non-speciftc stimuli such as damp or changes of temperature can also induce nasal symptoms in rhinitis, there are no reliable tests to measure nasal hyperreactivity in an objective way [4] . Non-specific reactivity of the nose can be measured by means of nasal provocation tesls with agents such as histamine and methacholine [4] . There is, however, no standard way of assessing the nasal response after provocation. In histamine provocation the increase in nasal airway resistance (NAR) is often used as a parameter of nasal response [5] [6] [7] but thenumber of sneezes [8] or even a "tickling score* [9] has been used for this purpose.
Several explanations for nasal hyperreactivity are possible., such as increased mucosal permeability, changes in irritant receptors or reflex activity and changes in vessels and glands of the nasal mucosii [10], The tendency for rhinitis patients to suffer from nasal stuffiness could perhaps also be explained by a nasal a-adrenergic dysfunction.
The aim of this study was two-fold. Originally, we tried lo establish the best agent for discriminating between ailergic rhinitis patients and healthy controls, using three provocative test agents: histamine. methacholine and phentolamine. The agents were chosen because oftheir different method ofaction on nasal mucosa. Histamine has an effect on both irritant receptors, thus stimulating nerves, and on vessels, thus causing nasal congestion [10] . Conversely, methacholine has a direct stimulating effect on glands [10] and phentolamine causes vasodilatation [II] . Secondly, we chose phentolamine. an alpha-receptor blocking agent, to investigate the a-adrenergic responsiveness ofthe nasal mucosa.
Subjects and methuds

Study design
Normal subjects and selected patients with a house dusl mite (HDM) allergy underwent nasal provocation tests with histamine. methacholine and phentolamine (in this sequence) on scparale days. The investigation period was restricted to 1 week for each patient. The group of healthy individuals v\as investigated during summer 1984 and the patients in September-November, this being the period with the highest number of housedust mites in Holland [12] .
Subjects
Thirteen patients (six females, seven males), with perennial rhinitis that had lasted for more than 1 year, took part in the study. Their ages ranged from 19 to . ' 'I with a median of 25 years.
Selection was based upon diagnosis of HDM allergy, confirmed by intradermal skin tests and radio-allergo-sorbent tesls (RAST). With skin-test titralion. positive reactions were found at low concentrations (I Noon unit/ml). Specific IgE to HDM extract was high (class 3 or 4). None had previously received immunotherapy. Five palients had u pollen aiiergy and live also had un allergy to pets {without having pets in the house). Eighteen healthy students {nine females, nine males), without clinical signs and symptoms of rhinitis or aslhma. participated in the study. Their ages ranged from 21 to 35 with a median of 25 years. None of the subjects had positive skin tests for a routine series ofinhalanl allergen extracts, neither had they specific IgE to HDM. grass pollen or cat dander, as measured with the RAST.
The study was approved by the Ethical Committee ofthe University Hospital and Medical Eaculty, Erasmus University, Rotterdam. Alt participants gave their informed consent before taking part in the study.
Agents
Histamine chloride was used in the following concentrations: 0 25. 0 5. I. 2. and 4 mg/ ml; methacholine in the concentrations S, 16, 32. and 64 mg ml; phentolamine in the concentrations 1, 2,4, and 8 mg/ml. The concentrations of phentolamine were chosen after consulting a cardiologist and taking into account the fad ihat na.sal absorption of the drug is virtually complete.
Na.sal responsivene.ss in alleri^ic rhinitis patients 565
Na.sal provocation tests In thccaseofthepatients, medication was withheld 2 days before the test. None ofthe subjects used topical corticosteroids or long-lasting aniihisiamines. Airway infections during ihe 2 weeks preceding the tests had been excluded.
On each occasion subjects waited half an hour before the test lo allow the nasal mucosa to become acclimatized. After rhinoscopy a control solution (phosphate buffered saline containing human serum albumin OO3' !^» and benzalkonium chloride 005"'..) was sprayed into the nostrils with a nasal pump spray delivering a fixed dose of 013 ml solution. After provocation wilh the conlrol solution, increasing doses of histamine chloride or methachotine or phentolamine were applied in both nostrils. The interval belween each dose was 5 min in ihc case of histamine and 15 min in the case of methacholine and phentolamine.
After each provocalion wilh histamine the subject was asked to bend forwards and to collect secretion in a syringe-equipped funnel, using the method introduced by Borum [13] . Sneezes were counted and just before ihc next provocation the NAR was measured three times. The median value was taken as the nasal airway resistance. When melhacholine was used, secretion only was collected as methacholine has no effect on nasal resistance [13] . In the case of phentolamine the NAR was monitored. The nasal resistance of each nostril was measured using a passive anterior rhinomanometer (Heyer PAR) as previously described [14] . This entailed blowing an air stream wilh a fixed flow of 0 25 I/sec into each noslril. The resistance for the left (^^i) and the right (Rr) cavity were calculated by dividing the nasal pressure by the flow. The total nasal resistance was computed from the formula:
Statistical analysis
Eor paired observations the Wilcoxon signed rank test was used. For comparison of the palients and controls the Wilcoxon rimk-sum test was used. A P value of 0 05 or less was considered as statistically significant. Results Seventeen healthy subjects participated in ihe histamine provocation tests and eighteen in the methacholine and phentolamine lesls. In the group of rhinitis palients thirteen hislamine. iwelve melhacholinc and eleven phentolamine provocation tests were done. One patient was withdrawn from the phentolamine provocation test because of dizziness. The three agents had dilferenl effects on the nose. Both histamine and phentolamine induced an inereasein nasal resistance in the control and patient groups but only in thecaseof phentolamine was the nasal response higher in the paiient jiroup than in the control group (Eig. I). No significant differences could be found in baseline NAR belween patients and controls in either histamine or phentolamine provocation tests (Table I ). Both histamine and methacholine induced a higher secretory response in the patient group than in the control group (Eig. 2). In contrast, phentolamine had no effect on the nasal secretion. Histamine was capable ofeliciting a sneeze reflex in the patient group (Eig. 3) whereas melhacholine induced sneezes in only four patients and phentolamine caused no sneezes at all. Significant side-eflects ofthe nasal provocation tests were not seen. In the case of phentolamine one patient complained of dizziness during phentolamine provocalion, however there was no objective change in pulse rate and blood pressure. Phentolamine used al a concentration of 8 mg/ml caused a transient painful burning sensation In the nose and so higher concentrations could not he used.
All median values plotted in Eigs 1-3 represent a large range of individual values. In order to discriminate between patients and controls in a way that is easy to use in clinical practice, we used an end-point titration method. Table 2 shows the histamine end-point concentrations using three different definitions of end-point. The metlian end-point concentrations required to double nasal resistance do not diflcr between ihe conlrol and patient groups. In contrast, median end-point concentration needed to give 0 5 ml secretion and/or five sneezes is eight times lower in the patient group than in the control group (0 50 vs 4 mg/trtl). A combination of symploms does not enable a better distinction lo be made between patients and controls.
A preliminary study of the variability of nasal provocation tests with histamine showed that the reproducibility oi' the test was better using the end-point concenlrations required to produce 0 5 ml secretion and/or live sneezes (to be published).
In the case of methacholine provocation the concentration needed to produce 0 5 ml secretion was at least 5 6 times lower in the patient group than in the conlrol group (22 6 vs 128 mg/ml or more, P<002; Wilcoxon rank-sum test). For phentolamine the concentration needed to double nasal resistance in the patieni group (4 r.v 8 mg, ml, /'<0 05; Wilcoxon rank sum test) vvas half that required for the controls.
Discussion
There are several studies of nasal response to non-specific stimuli [5-9, 13-20] but attempts to discriminate between patients and healthy subjects have lead to conflicting results [6 8. 13. 15 IH. 20 ]. The studies concerning nasal hyperreactivity differ from each other in the provocation technique, the way of assessing the symptoms and in selection of the patient population, which makes comparison of studies almost impossible. With our methods we observed a hypcrresponsiveness to histamine. methacholine and phentolamine in allergic rhinitis patients. There are several possibilities ihat can explain the results. Firstly, increased permeability of the diseased mucosa may enable a better penetration of ihe test agents. Conversely, the observation Table 2 . End-point concentration of hist;imin(.-(mg ml) in patients and controls that histamine has the same effect on the tiasal resistance of patients and controls, suggests thiU a ditference in permeability might be of minor importance. The fact that histamine leads to exaggerated secretory response and snee/e-retlex favours the second hypothesis, which is that the reflc.\-mcdiated activity in allergic patients is elevated.
A third possibility is thai changes in glands and vessels are responsible fot the observed hyperre;icli\ ity. The tendency to hypcrresponsiveness to phentolamine could possibly reflect a defect in the a-adrenergic system. Comparable assumptions have been made in bronchial asthma when using propanolol hyperresponsiveness is a measure ofa defect in the /f-adrenergic system. Our observation would correspond wilh the receptor-binding study of Ishibe ct al. [21] . who showed that there wjs a decrease in the number ofalpha-1-adrenergie receptors in the nasal mucosa of patients with nasal allergy. However, we cannot exclude the possibility ihat ihe response to phentolamine may merely reflect a tion-specific hyperreactivity. Another problem is ihat there was a slight, non-significant, dificrcncc in tnedian baseline nasal resistance between patients and controls before provociuion with phenlolamine. This ccaild theoretically inflticncc the outcome of ihe tcsis.
The finding ihat hisiamine has an equal effect on nasal resistance in patients and controls conflicts with other studies [7. H] . However, in our protocol the NAR was measured after a someiimes considerable amount of secretion had been collected m a syringe-equipped funnel. It could be ihal differences in nasal resistance measured after histamine provocalion in olher studies arc due lo a difference in the production of secretion. Another possible explanation is that measurLMiicnl of total nasal resistance is less reliable in deicciing differences than measurement ofone-sidcd nasal resistance. In a recent study Corrado ct al. [2(l| showed ihai only u few rhinitis patients allergic lo Dermatophagoides ptcronys.sinus respond to histamine provocation with rhinorrhoea. In our study, however, patients were tested in autumn, as this is the season with the highest exposure lo house dust mites. Recently we showed that nasal sensitivity to house dusl mile and probably lo histamine is increased in this season [22] , perhaps due to a priming effecl. The ittcreased rellcx mediated response found in our study could reflect the active state of the disease.
To our knowledge no prospective studies of nasai hypcrrcacliviiy li;t\c been carried out in large unselecled patieni groups. Uniil this is done the importance of nasal provocation tests in daily clinical practice remains uncertain.
However, by using un end-point tiiration tiiethod this sttidy provides a simple way of tneasuring nasal responsiveness and suggests that histumine is the best agent to use in nasal provocation tests to discriminate belween normal subjects and allergic rhinitis patients with active disease, provided ibat the assessment of nasal response is focused on the rcllcx action of histamine (i.e. sneezes and secretion). The role of rhinomanometry in this test may be questioned. The results obtained with phenlolamine provocation may reflect an x-adrenergic dysfunction ofthe nasal mucosa.
